Concept for feasibility review

Nicotinamide Mononucleotide (NMN) 500 mg

CapsuleGeneral Wellness

Preliminary source description

A cutting-edge NAD+ precursor that fuels cellular energy, supports healthy aging, and promotes metabolic vitality at the most fundamental level.

Proposed benefit themes

Themes for assessment only; they are not approved label claims.

Anti agingCellular energyMetabolismNad plus

Preliminary source ingredients

Vitamin B3 (Nicotinamide Mononucleotide) 500 mg

Preliminary source directions

Not final Canadian directions for use.

DOSE: As directed by a Healthcare Practitioner.

Illustrative market reference

Renue by Science NMN 500 mg

This unaffiliated reference is included only to illustrate a possible market category. Nostrum Health is not affiliated with, endorsed by, or representing the referenced brand, and no equivalence is implied.

Assess this concept for your project

Tell us your market, target format, quantities, timing, and current regulatory status. We will scope the commercial and regulatory feasibility review.

Enquire about this concept